Engineering chylomicron vesicles to target drugs to the liver may provide effective new treatments for hepatitis B and other liver diseases (pages 221–225).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ashwell, G. & Morell, A.D. The role of surface carbohydrates in the hepatic recognition and transport of circulation glycoproteins. Adv. Enzymol. 4, 99–128 (1974).
Huber, B.E. Late stage spermatids are characterized by expression of the ‘Liver-Specific’ asialoglycoprotein receptor. RHL-1 Molec. Pharmacol. 41, 639–644 (1992).
Mu, J.Z. et al. Asialoglycoprotein receptor mRNAs are expressed in most extraheptaic rat tissues during development. Am. J. Physiol. 264, G752–G762 (1993).
Fiume, L. et al. Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin. FEBS Lett. 103, 47–51 (1979).
Fiume, L. et al. Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by ara-A and ara-AMP conjugated to asialofetuin. FEBS Lett. 116, 185–188 (1980).
Torrani Cerenzia, M.R. et al. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy, minimal effective dose and plasma clearance of conjugate. J. Hepatol. 20 (2), 307–309 (1994).
Wu, G.Y. et al. Model for specific rescue of normal hepatocytes during methotrexate treatment of hepatic malignancy. Proc. natn. Acad. Sci. U.S.A. 80, 3078–3080 (1983).
Wu, G.Y. et al. Acetaminophen hepatoxicity and targeted rescue: A model for specific chemotherapy of hepatocellular carcinoma. Hepatology 5, 709–713 (1985).
Bijsterbosch, M.K. et al. Lactosylated low-density lipoprotein: A potential carrier for the site-specific delivery of drugs to Kupffer cells. Molec. Pharmacol. 36, 484–489 (1989).
Mommaas-Kienhuis, A.M. et al. Visualization of the interaction of native and modified low-density lipoproteins with isolated rat liver cells. Eur. J. Cell Biol. 38, 42–50 (1985).
Van der Sluijs, P., Bootsma, H.P., Postema, B., Moolenaar, F. & Meijer, D.F.K. Drug targeting to the liver with the lactosylated albumins. Does the glycoprotein target the drug, or is the drug targeting the glycoprotein?. Hepatology 6, 723–728 (1990).
Floren, C.H. & Nilsson, A. Binding, interiorization and degradation of cholesteryl ester-labelled chylomicron remnant particles by rat hepatocyte monolayers. Biochem. J. 168, 483–494 (1978).
Gregoriadis, G. & Florence, A.T. Liposomes in drug delivery: Clinical, diagnostic and ophthalmic potential. Drugs 45, 15–28 (1993).
Rensen, P.C.N., van Dijk, M.C.M., Havenaar, E.C., Bijsterbosch, M.K., Kruijt, J.K. & van Berkel, T.J.C. Nature Med. 1, 221–225 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hassan, N., Wu, G. Getting to the core of the matter. Nat Med 1, 210–211 (1995). https://doi.org/10.1038/nm0395-210
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0395-210
